Iain C Macdougall Selected Research

ferric carboxymaltose

12/2018	Randomized trial of intravenous iron-induced hypophosphatemia.
1/2018	A response by Strauss et al. to "a comment on the comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia".
1/2018	A controlled study of the effects of ferric carboxymaltose on bone and haematinic biomarkers in chronic kidney disease and pregnancy.
1/2018	Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial.
12/2017	Intravenous iron therapy in patients with chronic kidney disease: recent evidence and future directions.
10/2017	Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency.
9/2017	Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial.
1/2017	Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial.
1/2017	Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactions.
1/2016	Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Iain C Macdougall Research Topics

Disease

73	Chronic Renal Insufficiency 10/2022 - 03/2003
52	Anemia 02/2022 - 05/2002
33	Iron Deficiencies 02/2022 - 03/2002
16	Inflammation (Inflammations) 01/2022 - 01/2002
15	Hypoxia (Hypoxemia) 01/2022 - 07/2006
14	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 01/2003
12	Pure Red-Cell Aplasia 11/2018 - 11/2003
11	Heart Failure 01/2021 - 08/2012
9	Renal Insufficiency (Renal Failure) 11/2021 - 01/2002
9	Kidney Diseases (Kidney Disease) 01/2021 - 01/2008
8	Fatigue 01/2021 - 04/2011
7	Myocardial Infarction 12/2021 - 11/2012
7	Stroke (Strokes) 12/2021 - 11/2012
7	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 04/2019 - 04/2014
7	Anaphylaxis (Anaphylactic Shock) 11/2018 - 08/2005
7	Weight Loss (Weight Reduction) 01/2016 - 01/2008
6	Infections 05/2020 - 08/2007
5	Hypersensitivity (Allergy) 01/2018 - 01/2016
4	Obesity 01/2013 - 08/2007
3	Hypophosphatemia 12/2018 - 01/2017
3	Neoplasms (Cancer) 12/2014 - 04/2011
3	Hemorrhage 12/2014 - 01/2013
3	Body Weight (Weight, Body) 01/2013 - 11/2009
3	Necrosis 08/2004 - 01/2002
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2020 - 01/2020
2	Secondary Hyperparathyroidism 12/2018 - 04/2015
2	Drug-Related Side Effects and Adverse Reactions 11/2018 - 10/2016
2	Hypotension (Low Blood Pressure) 01/2018 - 01/2017
2	Iron Overload 01/2016 - 05/2013
2	Hypertension (High Blood Pressure) 01/2013 - 01/2010
2	Uremia 03/2012 - 09/2010
2	Type 2 Diabetes Mellitus (MODY) 04/2011 - 09/2010
2	Chronic Disease (Chronic Diseases) 01/2011 - 04/2006
2	Porphyrias (Porphyria) 12/2003 - 03/2002
1	Arteriovenous Fistula 01/2020
1	Fistula 01/2020

Drug/Important Bio-Agent (IBA)

63	IronIBA 02/2022 - 08/2005
39	HematinicsIBA 01/2022 - 02/2004
29	Erythropoietin FDA Link 12/2021 - 01/2002
22	Hemoglobins (Hemoglobin)IBA 01/2022 - 05/2002
14	ferric carboxymaltoseIBA 12/2018 - 01/2013
12	HepcidinsIBA 01/2017 - 01/2010
9	Saccharated Ferric Oxide (Venofer)FDA Link 01/2020 - 08/2005
8	Prolyl-Hydroxylase InhibitorsIBA 01/2022 - 01/2017
8	Darbepoetin alfa (Aranesp)FDA Link 01/2022 - 05/2002
8	Ferrosoferric Oxide (Magnetite)FDA Link 04/2019 - 04/2014
8	peginesatideIBA 11/2018 - 11/2011
7	Peptides (Polypeptides)IBA 01/2013 - 09/2008
7	AntibodiesIBA 03/2012 - 01/2002
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2002
6	Transferrin (beta 2 Transferrin)IBA 01/2022 - 01/2011
5	Epoetin Alfa (Epogen)FDA Link 01/2022 - 01/2004
5	Ferritins (Ferritin)IBA 02/2016 - 01/2011
5	epoetin betaIBA 03/2012 - 06/2003
4	GSK1278863IBA 01/2022 - 12/2021
4	C-Reactive ProteinIBA 11/2021 - 03/2013
4	Proteins (Proteins, Gene)FDA Link 12/2013 - 04/2004
4	CytokinesIBA 08/2004 - 01/2002
3	Serum AlbuminIBA 11/2021 - 12/2013
3	molidustatIBA 01/2019 - 01/2019
3	Erythropoietin Receptors (Erythropoietin Receptor)IBA 11/2018 - 11/2009
3	ApoferritinsIBA 09/2017 - 01/2016
3	Biological ProductsIBA 12/2014 - 05/2010
3	DefensinsIBA 01/2013 - 01/2010
3	Pharmaceutical PreparationsIBA 11/2011 - 05/2002
3	continuous erythropoietin receptor activator FDA Link 03/2008 - 11/2005
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2004 - 01/2002
3	Interferon-gamma (Interferon, gamma)IBA 08/2004 - 01/2002
2	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2019 - 07/2006
2	EnzymesIBA 01/2019 - 07/2006
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 03/2012
2	AdipokinesIBA 01/2016 - 10/2014
2	CreatinineIBA 12/2015 - 06/2003
2	Dextrans (Dextran)FDA Link 01/2013 - 12/2009
2	Orlistat (Xenical)FDA Link 01/2010 - 01/2008
2	hematideIBA 11/2009 - 09/2008
2	Pentoxifylline (Trental)FDA LinkGeneric 08/2004 - 07/2004
2	Interleukin-1 (Interleukin 1)IBA 01/2002 - 01/2002
1	ferric derisomaltoseIBA 01/2022
1	omega-Chloroacetophenone (Mace)IBA 12/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 05/2020
1	Vascular Endothelial Growth FactorsIBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	Calcitriol (Calcijex)FDA LinkGeneric 12/2018

Therapy/Procedure

48	Therapeutics 10/2022 - 01/2003
19	Renal Dialysis (Hemodialysis) 11/2021 - 01/2003
5	Kidney Transplantation 01/2019 - 01/2008
4	Drug Therapy (Chemotherapy) 01/2017 - 08/2007
4	Peritoneal Dialysis 11/2006 - 01/2003
3	Injections 01/2019 - 05/2002
3	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2018 - 06/2003
3	Blood Transfusion (Blood Transfusions) 05/2013 - 01/2008
2	Catheters 01/2020 - 04/2015
2	Gastrectomy 10/2014 - 01/2012
2	Exercise Therapy (Therapy, Exercise) 01/2013 - 10/2012
2	Subcutaneous Injections 11/2009 - 01/2004
1	Continuous Renal Replacement Therapy 01/2021
1	Perioperative Period 04/2020
1	Transplantation 01/2019